Richard H. White, MD; Estella Marie Geraghty, MD, MS, MPH; Ann Brunson, MS; et al.
free access
JAMA Intern Med. 2013;173(7):506-512. doi:10.1001/jamainternmed.2013.2352
White et al compared the frequency of vena cava filter (VCF) use for venous thromboembolism (VTE) among California hospitals in a 5-year retrospective observational study. A Viewpoint by Prasad et al follows.
Less Is More
Shayna Sarosiek, MD; Mark Crowther, MD; J. Mark Sloan, MD
free access
JAMA Intern Med. 2013;173(7):513-517. doi:10.1001/jamainternmed.2013.343
Sarosiek et al reviewed the medical records of patients with inferior vena cava filters at Boston Medical Center to determine patient demographics and the date of and indication for filter placement, as well as complications, follow-up data, date of filter retrieval, and use of anticoagulant therapy. See Original Investigation by White et al and Viewpoint by Prasad et al.
Marcello Maggio, MD, PhD; Andrea Corsonello, MD; Gian Paolo Ceda, MD; et al.
free access
JAMA Intern Med. 2013;173(7):518-523. doi:10.1001/jamainternmed.2013.2851
Maggio et al investigated the relationship between use of proton pump inhibitors and the risk of death or rehospitalization in older patients discharged from acute care hospitals. See also the invited commentary by Linsky.
Alexia M. Torke, MD, MS; Peter H. Schwartz, MD, PhD; Laura R. Holtz, BS; et al.
free access
has multimedia
JAMA Intern Med. 2013;173(7):526-531. doi:10.1001/jamainternmed.2013.2903
Torke et al conducted semistructured interviews of older adults to clarify their perspectives on screening cessation and their experiences communicating with physicians about this topic. See the invited commentary by Schonberg and Walter.
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
free access
JAMA Intern Med. 2013;173(7):534-539. doi:10.1001/jamainternmed.2013.2720
Singh et al tested whether glucagonlike peptide 1 (GLP-1)–based therapies such as exenatide and sitagliptin phosphate are associated with an increased risk of acute pancreatitis in a large administrative database of hospitalized patients.
Kristin M. Sheffield, PhD; Yimei Han, MS; Yong-Fang Kuo, PhD; et al.
free access
JAMA Intern Med. 2013;173(7):542-550. doi:10.1001/jamainternmed.2013.2912
Sheffield and colleagues determined the frequency of potentially inappropriate colonoscopy in Medicare beneficiaries in Texas and examined variation among providers and across geographic regions.
Gregory S. Cooper, MD; Tzuyung D. Kou, PhD; Douglas K. Rex, MD
free access
JAMA Intern Med. 2013;173(7):551-556. doi:10.1001/jamainternmed.2013.2908
Cooper et al studied a large population-based sample of Medicare beneficiaries undergoing outpatient colonoscopy to ascertain whether the potential risk of sedation-associated adverse events would be higher with the use of deep sedation. See also the invited commentary by Wernli and Inadomi.
Health Care Reform
Jason D. Wright, MD; Alfred I. Neugut, MD, PhD; Cande V. Ananth, PhD; et al.
free access
JAMA Intern Med. 2013;173(7):559-568. doi:10.1001/jamainternmed.2013.2921
To examine compliance with guideline-based recommendations for febrile neutropenia treatment, explore the factors that influence adherence to consensus guidelines, and analyze how the use of guideline-based care effects the outcome Wright and colleagues reviewed the Perspective database entries of 25 231 cancer patients with febrile neutropenia. See invited commentary by Chen.
Paul J. Hauptman, MD; John T. Chibnall, PhD; Camelia Guild, MPH; et al.
free access
JAMA Intern Med. 2013;173(7):571-577. doi:10.1001/jamainternmed.2013.3171
To examine patient-physician communication at the time the decision is made to implant an ICD, Hauptman et al conducted 8 focus groups in 3 metropolitan areas among 41 patients with ICDs. Separately, 11 cardiologists each performed 2 standardized patient interviews, and the data were analyzed. See also IIC120123 by Lin and Matlock.